Brilinta May Offer Protection Long After MI

January 14, 2015 7:40 PM

14 0

Brilinta May Offer Protection Long After MI

Top-line results from PEGASUS show secondary prevention benefits beyond 1 year.

Ticagrelor (Brilinta) reduced major cardiovascular events when given to patients 1 to 3 years out from myocardial infarction (MI), drugmaker AstraZeneca announced.

Also watch: Chris Kirk leads RSM Classic after firing a stunning 63 in first round

Read more

To category page

Loading...